%0 Journal Article
%T Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients
%A Ayman Alhazaymeh
%A Azam Shafquat
%A Bandar Al-Ghamdi
%A Majid Al-Fayyadh
%A Nadiah AlRuwaili
%A Waleed Al-Manea
%A Yaseen Mallawi
%J Archive of "Cardiology Research".
%D 2018
%R 10.14740/cr734w
%X Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited cardiomyopathy characterized histologically by the replacement of ventricular myocardium with fibrous and fatty tissue, and clinically by ventricular tachycardia arrhythmias primarily of right ventricular (RV) origin. Implantable cardioverter defibrillator (ICD) is the only proven therapy to reduce mortality in ARVC/D patients. However, it has the risk of inappropriate anti-tachycardia pacing (ATP) or shocks. This study aimed to assess the occurrence of appropriate and inappropriate ICD therapies in ARVC/D patients who underwent ICD implantation in a single Cardiac Centre
%K Implantable cardioverter defibrillator
%K Arrhythmogenic right ventricular cardiomyopathy
%K Shocks
%K Anti-tachycardia pacing
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089463/